Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 17 Oct 2025 – 20 Aug 2026, limited by The Wealth Company Ethical Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | The Wealth Company Ethical Fund | Nifty 500 |
|---|---|---|
| 17 Oct 2025 | ₹100.00 | ₹100.00 |
| 12 Nov 2025 | ₹99.40 | ₹101.01 |
| 07 Dec 2025 | ₹99.15 | ₹101.01 |
| 02 Jan 2026 | ₹100.05 | ₹102.12 |
| 27 Jan 2026 | ₹95.26 | ₹96.70 |
| 22 Feb 2026 | ₹96.39 | ₹99.14 |
| 20 Mar 2026 | ₹88.51 | ₹90.38 |
| 14 Apr 2026 | ₹92.46 | ₹93.99 |
| 10 May 2026 | ₹97.81 | ₹97.96 |
| 04 Jun 2026 | ₹96.35 | ₹95.34 |
| 30 Jun 2026 | ₹97.14 | ₹97.45 |
| 25 Jul 2026 | ₹95.78 | ₹97.10 |
| 20 Aug 2026 | ₹100.36 | ₹99.64 |
| Metric | The Wealth Company · Direct NAV ₹10.05 Very High risk Unrated | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| — | +7.23% | |
| — | +16.94% | |
| — | +14.70% | |
| — | +15.10% | |
| +0.36% | +14.07% | |
| +8.66% | — | |
| — | +17.59% | |
| — | +16.29% | |
| — | +16.00% | |
| Risk | ||
| 14.97% | 15.69% | |
| — | 0.52 | |
| — | 0.73 | |
| -14.66% | -23.08% | |
| Nifty 500 | — | |
| — | +4.66% | |
| — | 0.96 | |
| — | 109.1% | |
| — | 91.0% | |
| 1.18% | 1.14% | |
| ₹37.86Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹250 | — | |
| ₹1.00K | — | |
| — | 45% | |
| Aparna Shanker | — | |
| 17 Oct 2025 | — | |
| 45 | — | |
| 36.2% | — | |
| 1.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.